Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for Eton Pharmaceuticals (ETON) over the last 6 years, with Q3 2025 value amounting to $284000.0.

  • Eton Pharmaceuticals' Capital Expenditures changed N/A to $284000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $296000.0, marking a year-over-year increase of 201428.57%. This contributed to the annual value of $26000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Capital Expenditures is $284000.0.
  • In the past 5 years, Eton Pharmaceuticals' Capital Expenditures ranged from a high of $284000.0 in Q3 2025 and a low of $2000.0 during Q3 2021
  • Moreover, its 4-year median value for Capital Expenditures was $12000.0 (2022), whereas its average is $44250.0.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Capital Expenditures crashed by 9090.91% in 2021, and later skyrocketed by 20000.0% in 2022.
  • Quarter analysis of 4 years shows Eton Pharmaceuticals' Capital Expenditures stood at $4000.0 in 2021, then soared by 200.0% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2024, then soared by 2266.67% to $284000.0 in 2025.
  • Its last three reported values are $284000.0 in Q3 2025, $12000.0 for Q4 2024, and $14000.0 during Q1 2024.